LU76145A1 - - Google Patents

Info

Publication number
LU76145A1
LU76145A1 LU76145A LU76145A LU76145A1 LU 76145 A1 LU76145 A1 LU 76145A1 LU 76145 A LU76145 A LU 76145A LU 76145 A LU76145 A LU 76145A LU 76145 A1 LU76145 A1 LU 76145A1
Authority
LU
Luxembourg
Application number
LU76145A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU76145A1 publication Critical patent/LU76145A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
LU76145A 1975-11-07 1976-11-05 LU76145A1 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550011A DE2550011C2 (de) 1975-11-07 1975-11-07 Verfahren zur Herstellung eines antihämophilen Mittels

Publications (1)

Publication Number Publication Date
LU76145A1 true LU76145A1 (https=) 1977-06-03

Family

ID=5961172

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76145A LU76145A1 (https=) 1975-11-07 1976-11-05

Country Status (20)

Country Link
US (1) US4067964A (https=)
JP (1) JPS6029362B2 (https=)
AT (1) AT358737B (https=)
AU (1) AU500621B2 (https=)
BE (1) BE848111A (https=)
CA (1) CA1077393A (https=)
CH (1) CH630805A5 (https=)
DE (1) DE2550011C2 (https=)
DK (1) DK502176A (https=)
ES (1) ES452923A1 (https=)
FI (1) FI763165A7 (https=)
FR (1) FR2330408A1 (https=)
GB (1) GB1563009A (https=)
IL (1) IL50847A (https=)
IT (1) IT1063617B (https=)
LU (1) LU76145A1 (https=)
NL (1) NL7612139A (https=)
NO (1) NO763776L (https=)
SE (1) SE7612396L (https=)
ZA (1) ZA766647B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044343B1 (en) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4459288A (en) * 1981-05-11 1984-07-10 Baxter Travenol Laboratories, Inc. Therapeutic blood clotting factor compositions and their use
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
JP2931319B2 (ja) * 1989-03-29 1999-08-09 吉富製薬株式会社 血液凝固第▲ｖｉｉｉ▼因子の製造法
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
BR0207007A (pt) * 2001-02-05 2004-02-17 Novo Nordisk Healthcare Ag Composição farmcêutica, kit, usos de uma preparação e de uma composição, e, métodos para tratar de episódios de hemorragia em um paciente, para reduzir o tempo de coagulação em um paciente, para intensificar a hemostasia em um paciente para reduzir o número de administrações da proteìna do fator de coagulação necessário para deter a hemorragia e manter a hemostasia em um paciente, para reduzir a quantidade de proteìna do fator de coagulação administrada necessária para deter a hemorragia e manter a hemostasia em um paciente, para prolongar o tempo de lise do coágulo em um paciente, para aumentar a resistência do coágulo em paciente e para intensificar a formação de coágulo de fibrina em um paciente

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862002A (en) * 1962-05-08 1975-01-21 Sanfar Lab Inc Production of physiologically active placental substances
BE713764A (https=) * 1967-05-01 1968-09-16 Baxter Travenol Lab
BE787961A (fr) * 1971-08-24 1973-02-26 Behringwerke Ag Procede d'isolement d'une matiere thromboplastique et medicament contenant ladite matiere
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma

Also Published As

Publication number Publication date
CH630805A5 (de) 1982-07-15
IT1063617B (it) 1985-02-11
SE7612396L (sv) 1977-05-08
DK502176A (da) 1977-05-08
JPS5257310A (en) 1977-05-11
IL50847A (en) 1980-01-31
DE2550011A1 (de) 1977-05-12
ATA819476A (de) 1980-02-15
FR2330408B1 (https=) 1980-03-14
IL50847A0 (en) 1977-01-31
JPS6029362B2 (ja) 1985-07-10
ZA766647B (en) 1977-10-26
DE2550011C2 (de) 1982-11-25
GB1563009A (en) 1980-03-19
FI763165A7 (https=) 1977-05-08
NL7612139A (nl) 1977-05-10
AU1934176A (en) 1978-05-11
AT358737B (de) 1980-09-25
US4067964A (en) 1978-01-10
ES452923A1 (es) 1977-11-16
FR2330408A1 (fr) 1977-06-03
CA1077393A (en) 1980-05-13
BE848111A (fr) 1977-05-09
AU500621B2 (en) 1979-05-24
NO763776L (https=) 1977-05-10

Similar Documents

Publication Publication Date Title
JPS617423B2 (https=)
BG22692A1 (https=)
BG22607A1 (https=)
BG22641A1 (https=)
LU76145A1 (https=)
BG22870A1 (https=)
BG22941A1 (https=)
CH1222975A4 (https=)
CH585149A5 (https=)
CH586956A5 (https=)
CH587393A5 (https=)
CH587601A5 (https=)
CH589129A5 (https=)
CH590459A5 (https=)
CH591350A5 (https=)
CH595279A5 (https=)
CH596018A5 (https=)
CH596436A5 (https=)
CH597845A5 (https=)
CH598003A5 (https=)
CH598005A5 (https=)
CH599253A5 (https=)
CH599520B5 (https=)
CH599868A5 (https=)
CH600489A5 (https=)